Chattem R&D
This article was originally published in The Rose Sheet
Executive Summary
Health and beauty aids manufacturer will break ground for $2 mil., 10,000 sq.-ft. research and development facility in Chattanooga, Tenn. in February, company announces. Research facility, which is slated for completion by end of calendar year, will be dedicated to creating line extensions for existing products, according to President, Chief Operating Officer Alec Taylor. Gold Bond sales are expected to be $40 mil.- $42 mil. in 2002, and pHisoderm annual sales are expected to be in $15 mil.-$17 mil. range, Taylor reports during 1presentation at Banc of America Securities Equity and High Yield Research Household Products Conference Jan. 10...